vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Park Hotels & Resorts Inc. (PK). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $629.0M, roughly 1.5× Park Hotels & Resorts Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -32.6%, a 33.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 0.6%). Park Hotels & Resorts Inc. produced more free cash flow last quarter ($-3.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -0.8%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Park Hotels & Resorts is an American real estate investment trust (REIT) focused on hotel properties, based in Tysons, Virginia. It was formed in 2017 as a spin-off from Hilton Worldwide.

ASTH vs PK — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.5× larger
ASTH
$950.5M
$629.0M
PK
Growing faster (revenue YoY)
ASTH
ASTH
+42.3% gap
ASTH
42.9%
0.6%
PK
Higher net margin
ASTH
ASTH
33.3% more per $
ASTH
0.7%
-32.6%
PK
More free cash flow
PK
PK
$3.0M more FCF
PK
$-3.0M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
-0.8%
PK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
PK
PK
Revenue
$950.5M
$629.0M
Net Profit
$6.6M
$-205.0M
Gross Margin
Operating Margin
1.9%
-26.1%
Net Margin
0.7%
-32.6%
Revenue YoY
42.9%
0.6%
Net Profit YoY
184.4%
-410.6%
EPS (diluted)
$0.12
$-1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
PK
PK
Q4 25
$950.5M
$629.0M
Q3 25
$956.0M
$610.0M
Q2 25
$654.8M
$672.0M
Q1 25
$620.4M
$630.0M
Q4 24
$665.2M
$625.0M
Q3 24
$478.7M
$649.0M
Q2 24
$486.3M
$686.0M
Q1 24
$404.4M
$639.0M
Net Profit
ASTH
ASTH
PK
PK
Q4 25
$6.6M
$-205.0M
Q3 25
$373.0K
$-16.0M
Q2 25
$9.4M
$-5.0M
Q1 25
$6.7M
$-57.0M
Q4 24
$-7.8M
$66.0M
Q3 24
$16.1M
$54.0M
Q2 24
$19.2M
$64.0M
Q1 24
$14.8M
$28.0M
Operating Margin
ASTH
ASTH
PK
PK
Q4 25
1.9%
-26.1%
Q3 25
2.0%
9.7%
Q2 25
3.1%
9.7%
Q1 25
3.3%
1.1%
Q4 24
0.1%
13.3%
Q3 24
5.9%
14.6%
Q2 24
6.2%
17.6%
Q1 24
7.5%
14.4%
Net Margin
ASTH
ASTH
PK
PK
Q4 25
0.7%
-32.6%
Q3 25
0.0%
-2.6%
Q2 25
1.4%
-0.7%
Q1 25
1.1%
-9.0%
Q4 24
-1.2%
10.6%
Q3 24
3.4%
8.3%
Q2 24
3.9%
9.3%
Q1 24
3.7%
4.4%
EPS (diluted)
ASTH
ASTH
PK
PK
Q4 25
$0.12
$-1.04
Q3 25
$0.01
$-0.08
Q2 25
$0.19
$-0.02
Q1 25
$0.14
$-0.29
Q4 24
$-0.14
$0.32
Q3 24
$0.33
$0.26
Q2 24
$0.40
$0.30
Q1 24
$0.31
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
PK
PK
Cash + ST InvestmentsLiquidity on hand
$429.5M
$232.0M
Total DebtLower is stronger
$3.9B
Stockholders' EquityBook value
$779.3M
$3.1B
Total Assets
$2.2B
$7.7B
Debt / EquityLower = less leverage
1.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
PK
PK
Q4 25
$429.5M
$232.0M
Q3 25
$463.4M
$278.0M
Q2 25
$342.1M
$319.0M
Q1 25
$260.9M
$233.0M
Q4 24
$290.8M
$402.0M
Q3 24
$350.3M
$480.0M
Q2 24
$327.7M
$449.0M
Q1 24
$337.3M
$378.0M
Total Debt
ASTH
ASTH
PK
PK
Q4 25
$3.9B
Q3 25
$3.9B
Q2 25
$3.9B
Q1 25
$3.9B
Q4 24
$3.9B
Q3 24
$3.9B
Q2 24
$3.9B
Q1 24
$3.8B
Stockholders' Equity
ASTH
ASTH
PK
PK
Q4 25
$779.3M
$3.1B
Q3 25
$775.5M
$3.4B
Q2 25
$765.5M
$3.4B
Q1 25
$745.4M
$3.5B
Q4 24
$712.7M
$3.6B
Q3 24
$704.6M
$3.8B
Q2 24
$678.9M
$3.8B
Q1 24
$653.5M
$3.8B
Total Assets
ASTH
ASTH
PK
PK
Q4 25
$2.2B
$7.7B
Q3 25
$2.2B
$8.8B
Q2 25
$1.4B
$8.9B
Q1 25
$1.3B
$8.9B
Q4 24
$1.4B
$9.2B
Q3 24
$1.3B
$9.2B
Q2 24
$1.3B
$9.2B
Q1 24
$1.2B
$9.1B
Debt / Equity
ASTH
ASTH
PK
PK
Q4 25
1.23×
Q3 25
1.14×
Q2 25
1.12×
Q1 25
1.11×
Q4 24
1.06×
Q3 24
1.03×
Q2 24
1.03×
Q1 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
PK
PK
Operating Cash FlowLast quarter
$-2.9M
$105.0M
Free Cash FlowOCF − Capex
$-6.0M
$-3.0M
FCF MarginFCF / Revenue
-0.6%
-0.5%
Capex IntensityCapex / Revenue
0.3%
17.2%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$102.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
PK
PK
Q4 25
$-2.9M
$105.0M
Q3 25
$10.0M
$99.0M
Q2 25
$90.9M
$108.0M
Q1 25
$16.6M
$86.0M
Q4 24
$-10.9M
$80.0M
Q3 24
$34.0M
$140.0M
Q2 24
$23.2M
$117.0M
Q1 24
$6.0M
$92.0M
Free Cash Flow
ASTH
ASTH
PK
PK
Q4 25
$-6.0M
$-3.0M
Q3 25
$7.4M
$31.0M
Q2 25
$89.5M
$65.0M
Q1 25
$13.6M
$9.0M
Q4 24
$-13.5M
$17.0M
Q3 24
$31.7M
$97.0M
Q2 24
$20.4M
$66.0M
Q1 24
$5.6M
$22.0M
FCF Margin
ASTH
ASTH
PK
PK
Q4 25
-0.6%
-0.5%
Q3 25
0.8%
5.1%
Q2 25
13.7%
9.7%
Q1 25
2.2%
1.4%
Q4 24
-2.0%
2.7%
Q3 24
6.6%
14.9%
Q2 24
4.2%
9.6%
Q1 24
1.4%
3.4%
Capex Intensity
ASTH
ASTH
PK
PK
Q4 25
0.3%
17.2%
Q3 25
0.3%
11.1%
Q2 25
0.2%
6.4%
Q1 25
0.5%
12.2%
Q4 24
0.4%
10.1%
Q3 24
0.5%
6.6%
Q2 24
0.6%
7.4%
Q1 24
0.1%
11.0%
Cash Conversion
ASTH
ASTH
PK
PK
Q4 25
-0.44×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
1.21×
Q3 24
2.11×
2.59×
Q2 24
1.21×
1.83×
Q1 24
0.40×
3.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

PK
PK

Occupancy$371.0M59%
Food And Beverage$173.0M28%
Ancillary Hotel$61.0M10%
Hotel Other$24.0M4%

Related Comparisons